We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law What Science ACTUALLY Says About BPC 157 Benefits FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) FDA FDA to weigh easing limits on unproven peptides promoted by RFK Jr.